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The research question presented in this thesis was developed in collaboration with Dr Emma van Daalen, Child and Adolescent Psychiatrist at the University Medical Center Utrecht. She noticed that children who were evaluated at the department of child and adolescent psychiatry for neurodevelopmental disorders were relatively often born after assisted conception. She asked me to investigate this phenomenon, to see if there was an association between autism spectrum disorders (ASDs) and assisted conception. In the literature it is suggested that assisted conception may lead to ASDs through epigenetic modifications, which are heritable chemical modifications of DNA and its associated chromatin proteins, that are not changing the actual DNA sequence (Eun, Gan, & Chen, 2010; Feng, Jacobsen, & Reik, 2010). 
First, assisted reproductive technologies are discussed and it is hypothesized which components of the technologies may have an impact on epigenetic modifications leading to epigenetic errors. Second, ASDs and related imprinting disorders, which might be due to epigenetic errors, are discussed. Third, the epigenetic modification mechanism is discussed in detail, which includes what epigenetic modifications are, and how they are inherited via gametes that undergo epigenetic reprogramming, consisting of imprinting erasure and imprinting acquisition. 
It is important to examine a possible association between assisted conception and neurodevelopmental disorders, because the demand for assisted conception is increasing each year (de Mouzon et al., 2010), and more and more babies are born following assisted conception. If there is an association between ASDs and assisted conception, this might influence the prevalence rate of ASD among babies born after assisted conception. In this thesis it is hypothesized which components of assisted reproductive technologies might have an influence on epigenetic modifications. In concurrence, it is important to investigate this hypothesis further through an analysis of the frequency of assisted conception in a cohort of patients with ASD and to compare this frequency with the frequency of assisted conception in the population. Whereas an association between assisted conception and ASD might not be synonymous with a causal relationship, an association might put more impetus on the research into this relationship.
Hypothesizing a causal relationship between assisted conception and ASD might necessitate changes in or fine-tuning of components of assisted reproductive technologies in the future. Also, ASDs may be predicted or even prevented by children born after assisted conception. Knowledge on these influences need to be incorporated into genetic counseling for  infertile couples to enable them  to make a well considered choice on which or whether they would like to use assisted conception treatments. 
To obtain the information for this thesis a literature and practical study was done. The literature study was electronically performed in Pubmed and Omega, electronic databases of scientific articles. The practical study consisted of collecting data on patients with ASD and their method of conception.
Further research should be done on the association between ASDs and assisted conception. Therefore, this thesis is meant to be the start for further research on this subject. I thank Dr. Emma van Daalen for introducing this subject and together with Dr. Eva Brilstra for some interesting comments to improve this thesis. I also want to thank A. van der Zwaag and Gaby de Vries for showing me around the lab and giving me the opportunity to see how things work in the cytogenetic laboratory.
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A literature and practical study was performed to answer the hypothesis of this thesis. The information for the literature study was obtained through an electronic search in Pubmed and Omega, with the key words; “autism”, “autism spectrum disorders”, “Asperger syndrome”, “PDD-NOS”, “Rett syndrome”, “Angelman-Prader Willi syndrome”, “epigenetic modifications”, “epigenetic reprogramming”, “imprinting disorders”, “imprinting erasure”, “imprinting acquisition”, “assisted conception”, “assisted reproductive technology”, “IVF”, “ICSI”, and combinations of those words. The practical study consists of gathering information about patients from the Child and Adolescent Psychiatry department from the EPD (electronic patients files) and from the older patient files on paper. I have also had the chance to visit the lab of the cytogenetics department to see how a comparative genome hybridization (CGH)-array is performed. Also, I have attended psychiatric evaluations of children with neurodevelopmental disorders.
Literature study
1.	Introduction
During pregnancy the brain of the embryo is developing and functional changes of the brain are occurring (Dubovicky, 2010; Schendelaar et al., 2011). This process continues after birth, during childhood (Schendelaar et al., 2011), and also into  adolescence there is still maturation of the brain, including processes such as pruning and sprouting. During brain development specific time-frames exist in which the brain is sensitive to the influence of environmental factors, especially during the development of the embryo, that may result in some form of brain damage (Dubovicky, 2010). Environmental factors may be physical or chemical factors (Dubovicky, 2010) and are therefore not in itself genetic related factors (Langbehn, Cadoret, Caspers, Troughton, & Yucuis, 2003). The form and severity of the brain damage is depended on the dosage, the intensity and the duration of the exposure to the environmental factor and on the moment of exposure of the brain, i.e. the time-frame during the pregnancy and thus the developmental stage of the brain (Dubovicky, 2010).
Two of the most well-known environmental factors, influencing the brain of the embryo, are exposure to nicotine and alcohol through smoking and alcohol use. During pregnancy 12% of the women does not quit smoking and are therefore potentially creating a risk factor for the development of the brain of their child. Excessive exposure of the embryo to nicotine can cause cognitive and behavioral disorders, but also increases the risk of miscarriage (Dubovicky, 2010). Excessive alcohol use in the first trimester leads to a significant increase in birth defects, when compared with women who did not use alcohol. Alcohol use can lead to fetal alcohol spectrum disorders, which include (1) brain damage, that can lead to neurodevelopmental disorders, but also (2) a range of birth defects (O'Leary et al., 2010) and (3) fetal alcohol related abnormalities (FARA), which include fetal alcohol syndrome (FAS) (Dubovicky, 2010). FAS is the most severe form of FARA and includes facial anomalies, pre- and postnatal growth retardation, and impairment of the central nervous system (CNS), such as memory and learning deficits. Usually this severe form only occurs when there is excessive drinking of the mother during pregnancy. However, mild drinking can also cause brain damage to the fetus, known as alcohol related neurodevelopmental disorders (ARND). In ARND the damage is limited to the brain and is manifested through verbal and cognitive impairment. Both mild alcohol use and use of psychotropic drugs can lead to cognitive problems such as a dysfunction of attention (Dubovicky, 2010).
There are thousands of other environmental factors that can lead to congenital abnormalities, such as brain damage. Around two hundred synthetic chemicals of the thousands that exist are known to be neurotoxic in humans. 
When brain damage occurs this can result in neurodevelopmental disorders, leading to emotional, behavioral and/or cognitive dysfunctions. They are characterized by repetitive behavior, limited interest and include extensive abnormalities of communication and social interaction (Dubovicky, 2010). In agreement with earlier findings, data suggests that environmental factors influence the initiation and development of neurodevelopmental disorders, such as autism spectrum disorders (ASDs) (Dubovicky, 2010; X. Zhao, Pak, Smrt, & Jin, 2007). 

Neurodevelopmental disorders include, among others, autism spectrum disorders (ASD), that contains three subtypes (1) autism disorder (AD), (2) Asperger syndrome (AS), and (3) pervasive developmental disorder-not otherwise specified (PDD-NOS) (see chapter 3)(Grafodatskaya, Chung, Szatmari, & Weksberg, 2010; Myers & Johnson, 2007; Piggot, Shirinyan, Shemmassian, Vazirian, & Alarcon, 2009). Examples of environmental factors known to worsen or contribute to the development of ASDs are alcohol use and smoking (the outcome of these environmental factors are already discussed above), heavy metals, infectious disease, pesticides, prenatal stress (Dubovicky, 2010), and chemicals (Marques, Oliveira, Pereira, & Outeiro, 2010; Yu & Zhang, 2011). 
The individual or combined action of genetic and environmental factors can cause birth defects (Olson et al., 2005; Yu & Zhang, 2011), but also other diseases like cancer (Olson et al., 2005). Thus, for a normal development it is important for the embryo to be in an optimal condition (Dubovicky, 2010). Birth defects are congenital abnormalities and are the leading cause of death in babies under 1 year (Yu & Zhang, 2011). How exactly environmental factors contribute to birth defects stays unanswered till this day (Yu & Zhang, 2011). Environmental factors that can change gene expression in the zygote leading to birth defects , such as ASDs, are: among others; hypertension; excessive stress; toxins; hypoxia-ischemia (Dubovicky, 2010); a disturbed nutrition supply (Dubovicky, 2010; Marques et al., 2010); exposure to radiation; and drug use (Yu & Zhang, 2011). 
Gene expression can be changed in two ways; (1) through changing of the actual DNA sequence; (2) through modifying epigenetic modifications (Marques et al., 2010). The DNA sequence is inherited, just as epigenetic modifications are. They include DNA methylations, chromatin remodeling and histone modifications (see chapter 4) (Eun et al., 2010; Feng et al., 2010; J. Zhao, Whyte, & Prather, 2010; X. Zhao et al., 2007).
Assisted conception can affect the development of the embryo negatively (Olson et al., 2005). This might be related to ovarian hyperstimulation, or to the impact of the assisted conception procedures itself (Schendelaar et al., 2011). Multiple birth defects, such as cardiovascular birth defects, are particularly associated with in vitro fertilization (IVF), which is a form of assisted conception. A higher prevalence of AS was found in a sample of children born after IVF in comparison the prevalence of AS in the normal population (Olson et al., 2005). It is hypothesized that AS as well as the other ASDs might be due to epigenetic modification errors (Whitelaw, Vliet, & Oates, 2007). These errors may be induced by environmental factors (Marques et al., 2010). It is suggested that the side effect of IVF and other assisted conception may lead to these epigenetic modification errors (Olson et al., 2005). Thus, this suggests that assisted conception is an environmental factor that can result in epigenetic modification errors. The hypothesis of this thesis is; assisted conception is associated with ASDs and other related disorders due to epigenetic modification errors. For this thesis a literature and a practical study are  to investigate this hypothesis. The content of the literature study is; first, assisted conception; second, ASDs and other imprinting disorders; third, epigenetic modifications and epigenetic reprogramming.
2.	Assisted conception
2.1	Introduction to assisted conception
Assisted conception is a revolutionary technical development (Fortunato & Tosti, 2011) that is progressing enormously since the first test-tube baby was born in 1978 (Hartshorne, 2008; Laprise, 2009; Olson et al., 2005; Schendelaar et al., 2011). Besides, since more couples are becoming infertile assisted conception procedures are wanted. All the couples that could not have children now have an alternative to try and have their own family (ESHRE Capri Workshop Group, 2010). 
Assisted conception is also known as assisted reproductive technology (ART) (de Mouzon et al., 2010; Duwe, Reefhuis, & Honein, 2010; Marino, Moore, Rumbold, & Davies, 2011). ART includes, among others, intrauterine insemination (IUI) (de Mouzon et al., 2010; Marino et al., 2011), ovulation induction (OI) (Marino et al., 2011), and IVF, which, nowadays, include more invasive and sophisticated technologies such as intra-cytoplasmic sperm injection (ICSI) (de Mouzon et al., 2010; Duwe et al., 2010; Laprise, 2009; Marino et al., 2011), in vitro oocyte maturation (IVM) (Laprise, 2009), and zygote intrafallopian transfer (ZIFT) (Olson et al., 2005). In this thesis ART is any kind of artificial treatment that promotes conception.
Of the worldwide population 10% is infertile (Fortunato & Tosti, 2011) and infertility is still increasing. One of the reasons for this phenomenon is that couples are waiting longer before trying to get pregnant and consequently the women are older. With the increasing age of the women before they start bearing children, the risk of becoming less fertile or even infertile is also increased (ESHRE Capri Workshop Group, 2010).
 Among couples using ART treatment the age of the females is higher in comparison to couples that do not use ART treatments (Duwe et al., 2010). Also, couples using ART have a higher education level compared to couples that do not use ART (Marino et al., 2011). Possibly higher educated women are more likely to search for help in case of infertility in comparison to less-educated women (Marino et al., 2011). Together with maternal age and education level several other factors are associated with ART treatment, such as household income, race, and ethnicity (Duwe et al., 2010). 
Each year the number of ART treatments is increasing. For instance, in Europe in 2006 approximately 460,000 treatment cycles were done, which was an increase by 9.7% in comparison with 2005. In 2006 in the Netherlands 2.4% of the children born were conceived through ART (de Mouzon et al., 2010). These days more than 3 million children all over the world are conceived through ART (Hartshorne, 2008; Santos et al., 2010; Schendelaar et al., 2011) and 1% of all live births are conceived by ART (Fortunato & Tosti, 2011). Live births resulting from ART procedures have  more than doubled over 10 years (1996-2006) (Duwe et al., 2010). 
2.2	Assisted conception and epigenetics
As. Nevertheless, after the age of 31, of the man and woman  who want to get pregnant, the chance of giving live births through ART is decreased (ESHRE Capri Workshop Group, 2010). In addition, babies conceived by ART are associated with several other risks than decreased live births, such as prematurity,  maternal complications, low birth weight, perinatal mortality, multiple births, and birth defects (Duwe et al., 2010; Gelbaya, 2010). Still, the long-term outcome, of ART treatment, of neurological deficits is not exactly known (Schendelaar et al., 2011). However, as mentioned before, it is suggested that ART may influence epigenetic modification leading to errors (Olson et al., 2005), which may result in neurodevelopmental disorders, such as ASDs (Grafodatskaya et al., 2010; Myers & Johnson, 2007). In this chapter, hypotheses on possible epigenetic modification errors due to ART and the possible association with neuro-psychiatric disorders are discussed.
The chance of giving live births through ART is decreasing when the age of the couple is increasing, especially after the age of 31 years (Gelbaya, 2010). ART is associated with several other risks, such as prematurity,  low birth weight, perinatal mortality, multiple births, birth defects, chromosomal abnormalities  and maternal complications, such as. However, there are significant risks found, for the baby and the pregnant women, that correlate with ART (Santos et al., 2010). For example, a 30 times higher risk is found on a heterotopic pregnancy after ART treatment in comparison with natural conception. Also, together with the risks already mentioned, an increased risk of pre-eclampsia, bleeding during pregnancy, and a 30 times higher risk on a heterotopic pregnancy (ESHRE Capri Workshop GroupGelbaya, 2010). Although chromosomal abnormalities are associated with ART, there is still debate on whether or not ART actually is correlated to chromosomal abnormalities. For example, it was reported that no increased cytogenetic risk was seen in children conceived through ART after a karyotype analysis due to the use of ART procedures (Duwe et al., 2010; Gelbaya, 2010)(Fortunato & Tosti, 2011). Furthermore, many risks that are associated with ART are also associated with factors like reduced fertility or infertility, maternal age, smoking, obesity and multiple pregnancies, of which the last is one of the most important complications of ART. It is important to disentangle associated and causal risk factors (Fortunato & Tosti, 2011Gelbaya, 2010).
The association of epigenetics and ART is also under debate. Several is the association of epigenetics and ART. A definitive association between ART and epigenetics does not exist (Laprise, 2009). However, several studies show an increase in genomic imprinting disorders, with an epigenetic origin, among children conceived through ART (Gelbaya, 2010)(Laprise, 2009; Peters et al., 2009; Santos et al., 2010). It is known that germ cells are particularly sensitive to environmental changes, which may lead to epigenetic errors. In the case of ART many technical manipulations have to be performed with germ cells to purchase embryos. The germ cells are removed from their natural environment and exposed to handling, isolation, and culturing of the gametes (Laprise, 2009; Peters et al., 2009; Santos et al., 2010). Subsequently, the embryos are brought back into its natural environment, the uterus. The period directly after fertilization is hypothesized (by Ribas et al. (2006)) to be the most sensitive to epigenetic changes, (Peters et al., 2009). With ART procedures it is attempted to create an embryo ex vivo and during this period embryos conceived by ART are not in their natural environment (Santos et al., 2010)(Laprise, 2009). Epigenetics are reprogrammed during oogenesis and spermatogenesis. Thus it is of importance to evaluate during which step of ART treatment may be responsible for the induction of epigenetic errors takes place (Figure 1). The establishment of epigenetic modifications may not be completed in immature oocytes used for IVM (Peters et al.,Laprise, 2009). All the technical manipulations of ART treatment involve at least a chemical or mechanical manipulation and exposure of the cells and the embryos to an in vitro environment might lead to epigenetic errors, which may result in imprinting defects (Laprise, 2009; Peters et al., 2009; Santos et al., 2010). Exogenous hormonal stimulation, to initiate oocyte maturation, on the epigenetics of oocytes (Laprise, 2009; Peters et al., 2009; Santos et al., 2010). Exogenous hormonal stimulation is used in OI, to create multiple mature oocytes in one ovulation cycle. Hormonal stimulation may also be used in IUI and IVF to provide a more precise examination of the time-period for IUI or IVF in order to increase the chances of conception. Exogenous hormonal stimulation is also used with superovulation, which is an extreme version of OI (Laprise, 2009)(Georgia Reproductie Specialsts, 2007). It has been shown in mice that superovulation changes the expression and methylation, an epigenetic modification, of important genes imprinted with epigenetic modifications. Also, superovulation appears to have an adverse effect on oocyte quality and on the developmental fitness of several species, such as cows, sheep and rabbits (Georgia Reproductie Specialsts, 2007)(Laprise, 2009). Maternal methylation imprints are known to be especially susceptible for oocyte isolation and manipulation in culture, both associated with superovulation (Laprise, 2009)(Santos et al., 2010).
2.2.1	IVF and epigenetics
At this moment, IVF is a highly performed fertility treatment (Laprise,Peters et al., 2009), and is mainly used for female infertility problems, including tubal problems {{65 Peters,D.D. 2009; 76 Fortunato,A. 2011}}. The cause of reduced fertility of women is in 14% a tubal problem. Nowadays, IVF is also performed for male infertility problems, for example, direct injection of the sperm nucleus into the cytoplasm of the oocyte, ICSI {{76 Fortunato,A. 2011; 73 Gelbaya,T.A. 2010}}. Exogenous hormone stimulation, shown to have an adverse affect on epigenetic modifications of the embryo (Whitelaw et al., 2007), is the first step in IVF treatment. After that, the following steps are performed: oocyte retrieval and culture, followed by in vitro insemination with capacitated spermatozoa, than follows embryo culture, and finally the last step is transfer of embryos in the uterus (Fortunato & Tosti, 2011). Both successful (Fortunato & Tosti, 2011; Gelbaya, 2010) and unsuccessful treatment of IVF are known to be emotionally and physically stressful (Fortunato & Tosti, 2011; Gelbaya, 2010), which may also have a affect the embryo negatively (Peters et al., 2009). The negative effect on the embryo (Gelbaya, 2010). A significant increase in birth defects was seen in children conceived through IVF, although no significant differences were reported between IVF procedures, such as IVM, ICSI, and ZIFT (Olson (2005)., no significant differences were reported (Olson et al., 2005). An earlier mentioned and well known complication of assisted conceptions, in particular seen after IVF and ICSI procedures, is multiple pregnancies. This is probably due to the transfer of multiple embryos into the uterus. Multiple pregnancies lead to an increased risk for both the mother and the embryo. Multiple pregnancies is also associated with a low birth weight and pre-term delivery, and these are associated with an increased risk of brain damage. Indirectly, multiple pregnancies, and thus of IVF or ICSI, might lead to brain damage. Furthermore, it is suggested that babies conceived through IVF possibly have changed epigenetic modifications due to IVF procedures, resulting in Prader-Willi syndrome (PWS) or Angelman syndrome (AnS) (Peters et al., 2009)(Fortunato & Tosti, 2011). 

Figure 1. An overview of the point of removing of germ cells for ART treatments || This figure illustrates when germ cells are removed from their natural environment for ART treatment use (Laprise, 2009).
2.2.2	ICSI and epigenetics
ICSI is a more expended procedure from IVF and is performed since 1992 (Fortunato & Tosti, 2011)(Laprise, 2009). As a result, babies conceived through ICSI are 18 years of age at the maximum. The use of ICSI as well as of IVF is increasing. Though, IVF is the most performed treatment of the two treatments (Laprise, 2009)(de Mouzon et al., 2010). The procedure is used for male factor infertility, such as slow motility, low number and abnormal morphology of the spermatozoa (de Mouzon et al., 2010)(Fortunato & Tosti, 2011). These male factor infertilities may be due to chromosomal defects and the chromosomal defects may also lead to epigenetic disturbances (Fortunato & Tosti, 2011)(Laprise, 2009). In case of male factor infertility the spermatozoa are brought into the cytoplasm of the oocyte by direct microinjection, this process is called ICSI (Laprise, 2009)(Fortunato & Tosti, 2011). Besides male factor infertility, ICSI is increasingly used for mixed causes of infertility and unexplained infertility. These new indications may explain the increase of ICSI use (Fortunato & Tosti, 2011)(de Mouzon et al., 2010). However, using ICSI means that the normal evolutionary barriers for the use of spermatozoa of less quality for fertilization are bypassed, which might explain the increase ofmay lead to genetic defects in the embryo. As a result, the viability of the embryo can be affected and offspring may have to live with genetic abnormalities that may be caused by the use of ICSI treatment due to: (1) male infertility, as a causation of genetic mutations inherited from the father; (2) through ignorance of the cause of infertility, by lack of testing to determine the cause; and (3) potential impairment of the sperm DNA (de Mouzon et al., 2010)(Laprise, 2009) as an effect of the ICSI procedure itself, through the invasiveness of the injection, forced sperm selection and through interference with the fate of the spermatozoal structures (Laprise, 2009)(Fortunato & Tosti, 2011). Thus, damaged DNA used in ICSI may be the cause of genetic abnormalities (Fortunato & Tosti, 2011)(Laprise, 2009), however, it may also lead to epigenetic changes, resulting in genomic imprinting defects (Laprise, 2009Fortunato & Tosti, 2011).
3.	Autism spectrum disorders
3.1	Introduction to autism spectrum disorders
Autism Spectrum Disorders (ASDs) are pervasive neurodevelopmental disorders (Fortunato & Tosti, 2011)(Grafodatskaya et al., 2010; Myers & Johnson, 2007). ASDs are involving 3 subtypes, autism disorder (AD), Asperger syndrome (AS), and pervasive developmental disorder-not otherwise specified (PDD-NOS) (Grafodatskaya et al., 2010; Myers & Johnson, 2007; Piggot et al., 2009). Patients with ASDs are characterized by repetitive behaviors, and problems in social interaction, and communication (Grafodatskaya et al., 2010; Myers & Johnson, 2007; Piggot et al., 2009). Leo Kanner described autism, now known as AD, for the first time in 1943. The main problem of children with AD is social interaction with other people (Grafodatskaya et al., 2010)(Myers & Johnson, 2007). In 1944 Hans Asperger described, independently of Kanner, another group of children with symptoms similar to the symptoms that Kanner described. However, there was a difference; the children that Hans Asperger described had higher cognitive and verbal skills. This condition was called the AS (Myers & Johnson, 2007). PDD-NOS is the third subtype and the least understood condition (Myers & JohnsonMatson & Boisjoli, 2007). Although ASDs are highly heritable, the etiology is not fully understood. However, it is probably a combination of heritable and environmental factors (Matson & Boisjoli,Grafodatskaya et al., 2010; Whitelaw et al., 2007). ASDs are imprinting disorders and may be due to epigenetic modification errors. Epigenetic modifications are heritable but also may be influenced by environmental factors (see chapter 4) (Grafodatskaya et al., 2010). Therefore a close association is thought between ASDs and epigenetic modifications. Data suggests that environmental factors, that may affect epigenetic modifications, influence the initiation and development of ASDs (Dubovicky, 2010; X. Zhao et al., 2007). The prevalence of ASDs is 0.6% (Grafodatskaya et al., 2010; Whitelaw et al.,Holt, Barnby, & Maestrini, 2010; Maimburg & Vaeth, 2007; Myers & Johnson, 2007), and includes a male:female ratio of 4:1 (Grafodatskaya et al., 2010; Holt, Barnby, & Maestrini, et al., 2010; Maimburg & Vaeth, 2007; Myers & Johnson, 2007). In a few studies the numbers of the individual prevalences of the subtypes are given. One of these studies was in Canada, where the overall prevalence was 0.65%, the individual prevalences are for AD 0.22%, for AS 0.1%, and for PDD-NOS 0.33% (Grafodatskaya et al., 2010; Holt et al., 2010Myers & Johnson, 2007). 
3.2	Autism Disorder
Autism is a neurodevelopmental disorder. Hypotheses on the dysfunction of the brain in children with autism spectrum disorders have focused on brain connectivity, organization of neuronal tissue and synaptic function which could influence for instance the processing of information (Myers & Johnson, 2007). 
The symptoms of AD are by definition present before the child is three years of age (Dubovicky, 2010). The etiology of AD is still not clear, however, as stated above it probably is a combination of genetic and environmental factors (Grafodatskaya et al., 2010; Whitelaw et al., 2007). In addition, it is probably a complex combination of the interaction of multiple genes, the environment and epigenetic modifications (see chapter 4). Autism spectrum disorders can present themselves with symptoms when children are older than three years of age , although, it is hypothesized to be already present very early in development (Dubovicky, 2010). Valproic acid (histone deacetylase (HDAC) inhibitor) (Dubovicky, 2010)(Whitelaw et al., 2007) and thalidomide have shown to be able to cause disturbances of serotonegic neuronal development and neuro-behavioral alterations in animals, that might mimic autistic behavior. (Dubovicky, 2010). Thalidomide was given for morning sickness and as a sedative, and valproic acid as mood-stabilizing drug and in cases of epilepsy. When mothers have been using these psychopharmacological agents during pregnancy it is associated with autism in the offspring (Whitelaw et al., 2007).
A possible gene contributing to AD is the reelin (RELN) gene, which may also possibly be a candidate gene for other ASDs. RELN messenger RNA (mRNA) and protein were reduced in brains of children with autism and thus may probably contribute to AD. The promoter of RELN is sensitive for methylation, an epigenetic modification (Dubovicky, 2010)(Whitelaw et al., 2007). Also, a mutation in MBD1 is seen in patients with autism, which represents a CpG binding protein. There are two genes that, also, possibly contribute to the etiology of AD; (1) MeCP2 (see chapter 3.5.1), also a CpG binding protein, protein levels were reduced in the brain of children with autism (Whitelaw et al., 2007), which can be misleading because patients with Rett syndrome (RTT) also involves MeCP2 (Whitelaw et al., 2007)(Marco & Skuse, 2006); and (2) UBE3A (Marco & Skuse, 2006)(Whitelaw et al., 2007) also seen in Angelman (AnS) and Prader-Willi syndrome (PWS) (see chapter 3.5.3) (WhitelawGrafodatskaya et al., 20072010). This shows that AD and other imprinting syndromes are closely related to each other. Also, all the candidate genes are related with epigenetic modifications and therefore may be caused by epigenetic modification errors.
3.3	Asperger Syndrome
Asperger syndrome (AS) is the second neurodevelopmental disorder that is included in ASDs. Normally, a child will make friends, when attending a new school. However, a child with AS will have trouble making friends, which in many cases is the first clue for AS. Most AS patients are diagnosed later in their life than patients with AD, that are mostly diagnosed before the age of three. A child with AS is often referred to as a ‘little professor’, because they are overly formal in speech, this is called pedantic. In addition, they are mostly verbal about one topic, but are unable to express simple feelings. They are also pragmatic, which means that it is very hard for them to replace themselves in someone else, and they do not notice when a person looses interest in the topic of the conversation and do not know when to stop. Also, they are prosody, which means that their delivery of speech is different from normal people, regarding to intonation, volume, rhythm, and pitch. Regardless of being ‘little professors’ and being verbal about one topic, there certainly is a speech delay (Grafodatskaya et al., 2010)(Myers & Johnson, 2007). AS was found to be at higher prevalence among children born after IVF (Myers & Johnson, 2007Olson et al., 2005).
3.4	PDD-NOS
The third ASD is pervasive developmental disorder-not otherwise specified (PDD-NOS). There is no specific diagnosis of PDD-NOS, therefore it is only diagnosed when the criteria for other ASDs do not match (Olson et al., 2005)(Matson & Boisjoli, 2007). Thus, with a diagnosis PDD-NOS you actually say what it is not, instead of what it is. It is the most frequent ASD, but is also the one where they do little research on. PDD-NOS can be described as mild symptoms of autism and include problems in developing reciprocal social interaction, stereotypic behavior, verbal and non-verbal communication (Matson & Boisjoli, 2007).
3.5	Other imprinting syndromes
3.5.1	Rett Syndrome
Rett syndrome (RTT) is one of the syndromes that are closely related to ASDs. The symptoms of RTT and AD are quite similar, because of that individuals may be misdiagnosed with AD when they actually have RTT (Matson & Boisjoli, 2007)(Grafodatskaya et al., 2010). RTT was first described in 1966 by Andreas Rett (Grafodatskaya et al., 2010)(Marco & Skuse, 2006; Monnerat, Moreira, Alves, Bonvicino, & Vargas, 2010) and is a neurodevelopmental disorder (Chadwick & Wade, 2007; Grafodatskaya et al., 2010; Marco & Skuse, 2006; Monnerat, Moreira, Alves, Bonvicino, & Vargas, et al., 2010). While ASD individuals are mainly male (Chadwick & Wade, 2007; Grafodatskaya et al., 2010; Marco & Skuse, 2006; MonneratHolt et al., 2010), RTT affects more females (Grafodatskaya et al., 2010; Holt et al., 2010Marco & Skuse, 2006). RTT occurs in 1/10,000 to 15,000 baby girls (Grafodatskaya et al., 2010; Marco & Skuse, 2006; Monnerat et al., 2010). Individuals with RTT have a development arrest in 6 to 18 months (Marco & Skuse, 2006; Monnerat et al., 2010) and after this motor (Monnerat et al., 2010), language and social skills that were developed are going in regression (Monnerat et al., 2010)(Marco & Skuse, 2006). It is an X-linked syndrome and was thought to be lethal in males (Grafodatskaya et al., 2010; Marco & Skuse, 2006). However there are a few males found with a mutation in the causative gene methyl-CpG-binding protein 2 (MeCP2) (Grafodatskaya et al., 2010; Marco & Skuse, 2006). 
Now, it is known that RTT is in 80% of the cases caused by mutations in MeCP2 (Marco & Skuse, 2006)(Grafodatskaya et al., 2010). In spite of the similarities in clinical features between RTT and AD, the cause of AD is almost never due to mutations in MeCP2 (Grafodatskaya et al., 2010)(Marco & Skuse, 2006). However, there are ASD-associated MeCP2 mutations identified, which are in most of the cases intronic and on the 3’ untranslated region of MeCP2.  On the contrary,  RTT-associated MeCP2 mutations are mainly on the 5’ untranslated region or exonic (Marco & Skuse, 2006Grafodatskaya et al., 2010).
MeCP2 is thought to regulate the expression of the brain-derived neurotrophic factor gene (Bdnf), which is confirmed by a decreased level of Bdnf protein in MeCP2 knock-out mice. Both Bdnf or MeCP2 single mutant mice showed RTT-like symptoms, as well as double knock-out mice (Bdnf;MeCP2). However, lethality in double knock-out mice occurs earlier than in the single mutants. When in brains of MeCP2 knock-out mice  an overexpression of Bdnf was occupied, the appearance of RTT-like symptoms was delayed and so was the lethality (Grafodatskaya et al., 2010)(Chadwick & Wade, 2007). These experiments show an influence of Bdnf as well as MeCP2 on the outcome of RTT.
MeCP2 has many roles, e.g. on; epigenetic control of gene transcription, through chromatin remodeling, DNA methylation, and histone modifications;  alternative RNA splicing; and inhibition of transcription factor binding. MeCP2 has 2 functional domains, a methyl-CpG binding domain (MBD) and a transcription repression domain (TRD) (Chadwick & Wade, 2007)(Grafodatskaya et al., 2010; Monnerat et al., 2010). The MBD of MeCP2 associates to methylated CpG-islands (Grafodatskaya et al., 2010; Monnerat et al., 2010) A CpG-island is a linear base combination of a cytosine (C) and a guanosine (G) with a phosphate in between. The TRD of MeCP2 recruits HDACs and co-repressors, such as Sin3a, BRM, Ski, NCoR (Chadwick & Wade, 2007; Monnerat et al., 2010).
3.5.2	Fragile X syndrome
Another syndrome related to ASDs is Fragile X syndromes (FXS). Herbert Lubs identified in 1969 that the deficiency or absence of the fragile X mental retardation 1 (FMR1) gene causes FXS. A trinucleotide, CGG, repeat is present in the FMR1 gene, when a deficiency of FMR1 is the cause. If this repeat appears before a coding region this can directly impact the methylation of the gene, which can lead to transcriptional silencing, thus FMR1 is regulated by epigenetic modifications (Chadwick & Wade, 2007; MonneratGrafodatskaya et al., 2010; Marco & Skuse, 2006). Expansion of CGG repeats result in a histone deacetylation and DNA hypermethylation of FMR1, which result in less FMR1 protein, because the transcription of FMR1 is silenced (Grafodatskaya et al., 2010; Marco & Skuse, 2006). When the expansion of the CGG repeats are over 200 it is known as full-mutation (Grafodatskaya et al., 2010; Marco & Skuse, 2006), when there are 55-200 repeats it is called premutation, 45-54 repeats is called intermediate mutation, and 6-44 repeats is normal. Almost all full-mutation males have intellectual disability (ID), in contrast to most females who show less or no ID because they have a normal allele on the other X-chromosome. Full-mutation individuals have an increased ASD risk, in males this is 60% to 67%, when in females this is 10% to 23% (Grafodatskaya et al., 2010; Marco & Skuse, 2006). 
The FMR1 gene lies at chromosome Xq27 (on the long arm of the X-chromosome) and thus is an X-linked syndrome (Grafodatskaya et al., 2010; Marco & Skuse, 2006). Therefore it should not be a surprise that this syndrome affects more males than females. To be more precise, it affects 1 in 4000 males and 1 in 8000 females (Grafodatskaya et al., 2010; Marco & Skuse, 2006). Many FXS patients show autistic behavior, such as hyperarousal, atypical sensory responses, social anxiety,  impaired social reciprocity stereotypic behaviors, eye-gaze aversion, and delayed and atypical language (Grafodatskaya et al., 2010; Marco & Skuse, 2006).  Besides, 30% of the FXS patients are diagnosed with ASDs (Grafodatskaya et al., 2010; Marco & Skuse, 2006)
3.5.3	Angelman & Prader-Willi Syndrome
Last, Angelman Syndrome (AnS) and Prader-Willi Syndrome (PWS) are discussed, also related to ASDs (Marco & Skuse, 2006)(Laprise, 2009). Both AnS and PWS are due to the loss of function of imprinted genes in the chromosome gene cluster 15q11-13 (Laprise, 2009)(Buiting & Horsthemke, 2006; Grafodatskaya et al., 2010; Lalande et al., 2010; X. Zhao et al., 2007). This gene cluster is regulated by an imprinted centre (IC) and include genes expressed from both parental alleles; more specific, several paternally expressed genes, and the maternally expressed gene (see chapter 5.4) ubiquitin protein ligase E3A (UBE3A) (Buiting & Horsthemke, 2006; Grafodatskaya et al., 2010; Lalande et al., 2010; X. Zhao et al., 2007). In 70% of the AnS and PWS cases the loss of function is due to a deletion (GrafodatskayaX. Zhao et al., 20102007). A loss of function of the maternal chromosome, thus of UBE3A, leads to AnS, whereas a paternally loss of function, of the small nuclear ribonucleoprotein polypeptide N (SNRPN) gene, was seen in PWS (Buiting & Horsthemke, 2006; Laprise, 2009; X. Zhao et al., 2007). The incidence of AnS is 1 in 15,000 (Buiting & Horsthemke, 2006; Laprise, 2009; X. Zhao et al., 2007) and in 5% of the AnS cases a microdeletion in the IC of chromosome 15 is the result of a loss of function of UBE3A (Laprise, 2009). In detail, this microdeletion affects the 5’ end of the SNURF(SNRPN upstream reading frame protein)-SNRPN locus, which results in a loss of imprinting (LOI) in chromosome 15q11-13. This microdeletion can result in both AnS and PWS and are called imprinting defects because of LOI (Laprise, 2009)(Buiting & Horsthemke, 2006). In the general population Ans is not due to LOI but to maternal deletions or paternal uniparental disomy, in both cases no normal maternal allele is present. However, AnS associated with ART, in particular with ICSI, is mostly due to LOI of the maternal SNRPN allele (Buiting & Horsthemke, 2006)(Laprise, 2009). Besides an association between ART and AnS, also, both AnS and PWS are associated with an increased risk of ASD (Laprise, 2009)(Grafodatskaya et al., 2010).
4.	Epigenetic modification
4.1	Introduction to epigenetic modifications
During embryo development cells are duplicating to eventually form an organism. In embryo development three stages can be recognized; cell division, compaction, and formation of the blastocyst. During blastocyst formation an inner cell mass (ICM), trophectoderm (TE), and the outer cell mass, develops. The ICM will eventually form the embryo. Throughout the full development of the embryo it is very important that there is a proper regulation of gene expression , otherwise an abnormal embryo will develop. Epigenetic modifications play a major role in regulating gene expression, and are therefore critical for normal embryogenesis. The changes through embryo development of the epigenetic modification pattern and the regulation of transcription are unique (Grafodatskaya et al., 2010; J. Zhao et al., 2010). 
Epigenetic modifications are heritable enzyme-mediated chemical modifications of DNA and its associated chromatin proteins, that are not changing the actual DNA sequence (J. ZhaoEun et al., 2010; Feng et al., 2010). Epigenetic modifications include DNA methylation, chromatin remodeling, histone variants, histone substitutes deposition, and histone modifications, such as acetylation, phosphorylation, methylation and ubiquitination, and these modifications result in less or more accessible DNA and thus in regulation of gene expression (Eun et al., 2010; Feng et al., 2010; J. Zhao et al., 2010; X. Zhao et al., 2007).
Epigenetic modifications are inherited in a parent-of-origin specific way, this is called genomic imprinting. Thus genomic imprinting is the allele-specific gene expression, regulated by epigenetic modifications, inherited from the parents (Eun et al., 2010; Henckel et al., 2010; Feng2009; Singh et al., 2010; J. Zhao et al., 2010; X. Zhao et al., 2007). The genes that are imprinted with epigenetic modifications are called imprinted genes (Henckel et al., 2009; Singh et al., 2010; J. Zhao et al., 2010; X. Zhao et al., 2007). Gamete-specific DNA methylation is generated by DNMT3A and DNMT3B with DNMT3L. Most of the imprinted genes are involved in growth and neurodevelopment (Singh et al., 2010; Grafodatskaya et al., 2010) and that is why epigenetic modifications are important in fetal growth and development (Grafodatskaya et al., 2010; J. Zhao et al., 2010). 
Epigenetic modifications are important in cell differentiation, epigenetic reprogramming and imprinting ( J. Zhao et al., 2010; Feng et al., 2010). And are therefore playing important roles in completion of meiosis and the correct differentiation during gametogenesis, and, through imprinting and epigenetic reprogramming, in passing on reliable retaining information in gametes (Feng et al., 2010; Eun et al., 2010), but also  erasure of improper epigenetic modifications to prevent epimutations (Eun et al., 2010; Feng et al., 2010).
4.2	Chromatin Remodeling
In eukaryotic cells the DNA in the nucleus is packed in nucleosomes. A nucleosome is a complex of DNA wrapped in histone octamers. These nucleosomes together are compacted in a structure named chromatin (Eun et al., 2010; Feng et al., 2010; J. Zhao et al., 2010). The chromatin can be reconstructed and is called chromatin remodeling, which is an epigenetic modification and thus plays a role in gene expression (Eun et al., 2010; J. Zhao et al., 2010). The nucleosome position, organization and composition change during chromatin remodeling ( J. Zhao et al., 2010; Eun et al., 2010).
Remodeling of the chromatin occurs through three mechanisms. First, by replacing core histones with histone variants. Second, ATP-dependent chromatin remodeling, removal or repositioning of histone octamers. Third, epigenetic modification of the histone protein tails (Eun et al., 2010; Juelich et al., 2009). It is also known that epigenetic modifications regulate transcription factor binding to gene promoters (Juelich et al., 2009; J. Zhao et al., 20092010). 
4.3	DNA methylation
As earlier mentioned in this thesis chromatin remodeling regulates gene expression, but it also influences the methylation patterning (J. Zhao et al., 2010; Feng et al., 2010). DNA methylation is one of the best understood epigenetic mechanisms (Feng et al., 2010; Eun et al., 2010) and is associated with transcriptional repression (Eun et al., 2010; J. Zhao et al., 2010; Zhu, 2009). This occurs in five ways; (1) direct repression due to inhibition of transcriptional activators binding, (2) indirect repression through binding of methyl DNA-binding proteins that result in the formation of a repressive chromatin (J. Zhao et al., 2010; Zhu, 2009), (3) direct repression by masking enhancers, (4) indirect repression via methylation that diminish the efficiency of transcription, and (5) indirect repression by DNMT-mediated chromatin remodeling (J. Zhao et al., 2010; Zhu, 2009).
DNA methylation can occur on three different nucleotide sequences, on the cytosine-residue of the dinucleotide CpG (CpG islands), which occurs the most (Feng et al., 2010; J. Zhao et al., 2010; X. Zhao et al., 2007; X. Zhao et al., 2007), and on CHG or on CHH (H stands for a C, T or A), which are present in a smaller amount (Feng et al., 2010; J. Zhao et al., 2010; X. Zhao et al., 2007; X. Zhao et al., 2007). The maintenance DNA methyltransferases, DNMT1 (DNA (cytosine-5-)methyltransferases 1), maintains the CpG island methylations (Feng et al., 2010). DNMT1 is present during demethylation to maintain certain methylations (Feng et al., 2010; Zhu, 2009). However some loci with DNA methylation on CpG islands require DNMT3A and DNMT3B to maintain, these DNMTs are de novo DNA methyltransferases (Zhu, 2009Feng et al., 2010). The DNA methylations on these CpG islands regulate imprinting (Feng et al., 2010; J. Zhao et al., 2010). CHG and CHH methylations, particularly seen in stem cells, are likely to be innovated by these de novo DNMTs, DNMT3A and DNMT3B (J. Zhao et al., 2010; Feng et al., 2010).
The regions in the DNA where the de novo DNA methylations are established are called differentially methylated regions (DMRs) and are maintained during somatic cell division (Feng et al., 2010; Arnaud & Feil, 2005; Singh et al., 2010). When the origin of the DNA methylations is from either the male or female gamete it is a ‘germline DMR’. When the origin of the DNA methylation is parental-allele-specific, independently from male or female, they are called ‘somatic DMRs’ (Figure 2) (Arnaud & Feil, 2005; Singh et al., 2010). There are DMRs that can control imprinted gene expression, which are named imprinting control regions (ICRs) (Arnaud & Feil, 2005; Singh et al., 2010).
All this together shows us that DNA methylation changes throughout embryo development (Arnaud & Feil, 2005; Singh et al., 2010; J. Zhao et al., 2010).

4.4	Histone modifications
Just like DNA methylation, histone modifications change during embryogenesis (J. Zhao et al., 2010). For epigenetic regulation DNA methylation and histone modifications interact with one another (Eun et al., 2010; J. Zhao et al., 2010). Histone modifications are controlled by histone modifying enzymes, such as histone deacetylase (HDAC). In mice histone modifying enzymes with opposite actions are both required for a correct meiosis (Eun et al., 2010; J. Zhao et al., 2010). There are three different kind of histone modifying enzymes. First, there are the enzymes that generate histone modifications, also known as the ‘writers’ (Eun et al., 2010), such as histone methyltransferases (Eun et al., 2010; Feng et al., 2010). Second, the ‘readers’, which are enzymes that recognize histone modifications. And then there is the third group, which are enzymes that erase histone modifications, such as histone demethylases (Eun et al., 2010; Feng et al., 2010). As earlier mentioned histone modification includes acetylation, phosphorylation, methylation and ubiquitination (Eun et al., 2010; J. Zhao et al., 2010). Active transcription is generally related to histone acetylation. Because of the acetylation the interaction between DNA and histone is decreased and the DNA becomes more accessible for transcription. On the other hand histone methylation is associated with activation or repression. Whether the methylation activates or represses transcription depends on the residue that is modified (Eun et al., 2010; J. Zhao et al., 2010). Histone modifications are thought to be maintained through DNA replication, by association of histone modifying enzymes with the DNA replication machinery (J. Zhao et al., 2010; Feng et al., 2010).
5.	Epigenetic reprogramming
5.1	Introduction to epigenetic reprogramming
As previously mentioned epigenetic modifications are very important for the regulation of gene expression and are therefore important for a normal embryogenesis. Besides epigenetic modifications diploidy is also very important. It is shown in mice that a zygote with two sets of maternal chromosomes (gynogenotes) or two sets of paternal chromosomes (androgenotes) have an abnormal development. In both cases the development was arrested at a certain point. Gynogenotes had underdeveloped extraembryonic tissues, however the embryo was small but normal. Androgenotes showed an opposite development, the extraembryonic tissues were normal, but the development of the embryo was arrested at a four- to six-somite stage. Thus, two sets of chromosomes, one maternal and one paternal, are needed for a normal embryo development (Feng et al., 2010)(Arnaud & Feil, 2005). It is known that the epigenetic modifications inherited from the mother or the father is different (Arnaud & Feil, 2005)(J. Zhao et al., 2010). Thus the reason that chromosomes from both parents are required will probably be due to genomic imprinting (J. Zhao et al., 2010)(Arnaud & Feil, 2005). 
Germ cells are immortal and within one generation it is therefore important that they undergo proper cellular differentiation. Furthermore they are the cells that provide the DNA for the next generation. Thus it is important that the DNA with its epigenetic modifications is accurate for heredity and for a proper initiation of the next generation (Arnaud & Feil, 2005Eun et al., 2010). 
As earlier defined genomic imprinting are genes with imprinted epigenetic modifications, imprinted genes, and are inherited in a parent-of-origin specific way (Eun et al., 2010; Henckel et al., 2009; Singh et al., 2010; J. Zhao et al., 2010; X. Zhao et al., 2007). Gametogenesis is the differentiation of diploid germ cells into haploid gametes. During gametogenesis the imprinted genes in germ cells are reprogrammed and go through an imprinting life cycle, epigenetic reprogramming (Henckel et al., 2009; Singh et al., 2010; J. Zhao et al., 2010; X. Zhao et al., 2007)(Arnaud & Feil, 2005). In this process the germ cells become totipotent gametes. They can form, upon fertilization, all cells for a complete organism (Arnaud & Feil, 2005)(Eun et al., 2010; J. Zhao et al., 2010). The epigenetic memory from the germ cells in one generation is passed on to the next through epigenetic reprogramming. Through mitotic and meiotic cell divisions this cellular memory maintains the fate of the cell (Eun et al., 2010; J. Zhao et al., 2010).
Epigenetic reprogramming is essential; it prevents passing on epimutations, conveys epigenetic modifications between cells and between sexual generations. It occurs in primordial germ cells (PGCs) (Eun et al., 2010; Feng et al., 2010), which transform into germline stem cells (GSCs) (Feng et al., 2010; Eun et al., 2010). GSCs induce gametogenesis and premature differentiation of GSCs is prevented by chromatin remodeling, via ISWI. During gametogenesis DNA methylation at DMRs are maintained (Eun et al., 2010). 
In PGCs there is a short period of time when no parent-of-origin imprints are seen. Epigenetic reprogramming during PGC development is responsible for this phenomenon, because imprinted DNA methylations are erased, but new parental methylations are not yet purchased(Eun et al., 2010; J. Zhao et al., 2010). Epigenetic reprogramming is also seen in the early embryo after fertilization. It includes erasure of DNA methylation and loss of histones, histone variants and histone modifications (J. Zhao et al., 2010; Feng et al., 2010), but also the acquisition of DNA methylation and histone modifications (Feng et al., 2010)(Arnaud & Feil, 2005). When an incorrect epigenetic reprogramming of germ cells takes place fertility and germline differentiation are affected, in addition it also reduces the length of cell life and the fitness of the cells (Arnaud & Feil, 2005; Eun et al., 2010). 

Figure 2. Mammalian epigenetic reprogramming || First active and/or passive DNA demethylation occurs, than de novo DNA methylations are established. (i) Active demethylation of the male pronucleus occurs in the zygote(blue), the maternal nucleus (pink) stays unaffected. (ii) Both genomes undergo passive demethylation and after that de novo methylations are established during blastocyst formation. (iii) In PGCs active and passive demethylation occurs. Somewhere in between PGCs and mature gametes de novo methylations are established, however the exact timing is not known (adapted form (Gehring et al., 2009)).

Epigenetic reprogramming occurs at two time points; (1) in the PGCs of the embryo until either a sperm or oocyte is formed (Eun et al., 2010)(Gehring, Reik, & Henikoff, 2009) and once again a totipotent state is obtained in the gametes (Gehring, Reik, & Henikoff, 2009)(Eun et al., 2010; J. Zhao et al., 2010), (2) and in the zygote until a blastocyst is formed ( Eun et al., 2010; Gehring et al., 2010; J. Zhao et al., 2010). Epigenetic reprogramming consists of two processes (Gehring et al., 2010; Eun et al., 2009 2010; J. Zhao et al., 2010), imprinting erasure and imprinting acquisition. First, imprinting erasure occurs at the beginning of germline differentiation and immediately after fertilization, in which the epigenetic modifications are erased. Second, imprinting acquisition takes place at a late stage of germline development and during the blastocyst formation, in which new imprints are added (Eun et al., 2010; J. Zhao et al., 2010)(Arnaud & Feil, 2005). However, there are no histone modification or demodification enzymes discovered (Arnaud & Feil, 2005)(Feng et al., 2010), which emphasizes how little is known about reprogramming of histone modifications. On the other hand the reprogramming of DNA methylations is much clearer. Besides reprogramming of histone modifications is more complex than the reprogramming of DNA methylations (Feng et al., 2010; J. Zhao et al., 2010). Therefore emphasize is on the reprogramming of DNA methylations.
5.2	Imprinting erasure
One of the two time points where imprinting erasure occurs is in PGCs at the beginning of gametogenesis (J. Zhao et al., 2010)(Arnaud & Feil, 2005). During embryonic day (E) 11.5-12.5, PGCs are entering the genital ridge and after proliferation (till E13.5) they either undergo mitotic arrest (males) or enter meiotic prophase (females) (Arnaud & Feil, 2005)(Gehring et al., 2009). Imprinting erasure occurs between E10.5 and E13.5 and thus before the PGCs enter the mitotic arrest or enter meiosis (Arnaud & Feil, 2005; Feng et al., 2010; Gehring et al., 2009). Reprogramming is important because it includes the erasure of abnormal epigenetic modifications, which prevents passing on epimutations (Arnaud & Feil, 2005; Feng et al., 2010; Eun et al., 2010; Gehring et al., 2009). 
5.2.1	DNA demethylation
During embryo development cells duplicate and therefore DNA replication, DNA repair and transcription is needed. Transcriptional regulation, DNA replication and DNA repair are all under the influence of chromatin remodeling (Gehring et al., 2009; J. Zhao et al., 20092010). There are three DNA repair pathways; (1) mismatch repair, (2) nucleotide excision repair (NER) and (3) base excision repair (BER) (J. Zhao et al., 2010; Feng et al., 2010) It is thought that DNA demethylation is a two-step process, an active and passive demethylation (Feng et al., 2010; Arnaud & Feil, 2005; Gehring et al., 2010 2009; Zhu, 2009). First active demethylation, which is regulated by the DNA repair mechanism, and then passive demethylation takes place (Figure 2) (Arnaud & Feil, 2005; Gehring et al., 2009; Zhu, 2009). Passive demethylation is dependent on DNA replication and is the result of inactive maintenance methyltransferases. When the maintenance methyltransferases are active, they will add new DNA methylations after DNA replication. However, in this situation the maintenance methyltransferases are inactive and thus the newly synthesized DNA strand remain unmethylated (Gehring et al., 2009; Zhu, 2009). Unlike passive demethylation, active demethylation is independent from DNA replication and is therefore faster and called the rapid and active demethylation (Gehring et al., 2009; Zhu, 2009). After fertilization of the egg, only the paternal genome is actively demethylated (Zhu, 2009)(Arnaud & Feil, 2005; Feng et al., 2010; J. Zhao et al., 2010).There are three general mechanisms for active demethylation, two (2, 3) that involve DNA repair; (1) the methyl group can be directly removed, (2) NER removes several nucleotides from a single-stranded DNA containing 5-methylcytosine (5meC) (Arnaud & Feil, 2005; FengGehring et al., 2010; J. Zhao et al., 20102009), and (3) BER which leads to the replacement of 5meC with cytosine in two ways (Figure 3) (Feng et al., 2010; Gehring et al., 2009; J. Zhao et al., 2010; Zhu, 2009). DNA glycosylases are BER proteins and they mediate the active DNA demethylation (Feng et al., 2010; Gehring et al., 2009; J. Zhao et al., 2010; Zhu, 2009). The DNA glycosylases recognize the methylated cytosine, 5meC, and cleaves the DNA. Now the 5meC can be removed and replaced by an unmethylated cytosine. However, BER can also act after an activated-induced (cytosine) deaminase (AID) deaminates the 5meC into thymine, which is the second possibility to remove 5meC with BER (Gehring et al., 2009; Zhu, 2009). In mammals, this second BER active demethylation mechanism appears to be predominant in comparison with the first BER mechanism (Gehring et al., 2009; Zhu, 2009). The DNA glycosylase now replaces the nucleotide thymine with an unmethylated cytosine (Gehring et al., 2009; Zhu, 2009). In conclusion a genomewide passive and active DNA demethylation takes place in embryo development (Gehring et al., 2009; Zhu, 2009)(Arnaud & Feil, 2005). Still there are regions that remain unaffected and thus are not demethylated (Arnaud & Feil, 2005; Zhu, 2009), such as paternally methylated imprinted genes (Arnaud & Feil, 2005; Zhu, 2009). 
Active demethylation occurs at two points; (1) in PGCs, where also a passive demethylation takes place and (2) in the male pronucleus in the zygote (Gehring et al., 2009; Zhu, 2009). With DNA demethylation in PGCs the parent-of-origin-specific imprints are erased. The importance of this is that later on the correct acquisition of the specific imprints linked to the sex of the germline can be established (Feng et al., 2010; Gehring et al., 2009; Zhu, 2009). This DNA demethylation is also important for germline-specific genes, which are needed for proper germ cell differentiation and meiosis. After demethylation of the promoters of germline-specific genes they become active and the genes are transcribed at least at E13.5, when demethylation is completed (Feng et al., 2010; Gehring et al., 2009). After active DNA demethylation in the male pronucleus in the zygote a passive demethylation during pre-implantation development of both genomes follows (Figure 4) (Feng et al., 2010; Arnaud & Feil, 2005; Gehring et al., 2009).
To illustrate the various number of methylation in different cell types, the experiment in mice performed by Feng (2010) (Arnaud & Feil, 2005; Gehring et al., 2009; Feng et al., 2010) shows a great difference between the amount of methylation in PGCs, compared to embryonic stem cells (ESCs) and somatic cells. Only 7% of CpG islands remain methylated, whereas in ESCs and somatic cells 70-80% remains methylated (Feng et al., 2010).
5.3	Imprinting acquisition
As well as imprinting erasure, imprinting acquisition takes place at two time points, in PGCs and during gametogenesis. Only, the imprinting acquisition is later on in the gametogenesis in comparison with imprinting erasure (Zhu, 2009)(Arnaud & Feil, 2005). The timing of imprinting acquisition in PGCs is not exactly known. However, in mouse it is shown that the time of imprinting differs in male and female. In male germline cells the acquisition begins in mitotically arrested prospermatogonia before birth. In contrast to male, acquisition in female germline cells the acquisition begins after birth during the maturation of the oocytes (Figure 1) (Arnaud & Feil, 2005).
After genomewide active demethylation of the male pronucleus and passive demethylation of both genomes during the pre-implantation development, imprinting acquisition in the embryo of de novo methylations occurs after implantation during blastocyst formation (Figure 4) (Arnaud & Feil, 2005; Feng et al., 2010; Gehring et al., 2009; J. Zhao et al., 2010). The blastocyst forms the ICM and TE. At this point the ICM becomes hypermethylated in comparison with TE (Arnaud & Feil, 2005; Feng et al., 2010; Gehring et al., 2009; J. Zhao et al., 2010). 

Figure 3.  Three general mechanisms for active DNA demethylation || (1) Active demethylation of the DNA repair BER mechanism, (2) of the DNA repair NER mechanism, (3) and direct removal of the methyl group (through hydrolysis and releasing it as methanol or oxidative demethylation). (a) The BER protein 5meC DNA glycosylase removes 5meC by excising it, after which it is replaced with an unmethylated cytosine-residue. (b) AID deaminates 5meC into thymine, than G/T mismatch DNA glycosylase removes T and replaces it with an unmethylated C (adapted form (Zhu, 2009)).

DNMTs maintain or take care of the acquisition of methylation at DMRs. There are two forms of DNMTs, the somatic-derived form and the oocyte-derived form (Feng et al., 2010; Gehring et al., 2009; J. Zhao et al., 2010). DNMT1 maintains methylations at DMRs (Feng et al., 2010; J. Zhao et al., 2010). The DNMTs responsible for the de novo methylations are DNMT3A, -B, -C. By the blastocyst stage the oocyte-derived DNMT3A disappears, which again indicates that imprinting acquisition takes place during blastocyst formation but before completion (Feng et al., 2010; J. Zhao et al., 2010). 
5.4	Maternal in comparison with paternal epigenetics




Figure 4. Schematic picture of epigenetic reprogramming throughout development || The outer ring shows at which point in the development the processes happen. The thickness of the arrows indicate the amount of DNA methylations. The orange ring indicates the beginning of DNA methylations and the blue ring the beginning of the DNA demethylation. DNA demethylation in the zygote is active and only occurs in the male pronucleus (blue) and not in the female (pink). The DNA demethylation in the PGCs is active and passive. The inner red arrows indicate when the concerning proteins are expressed. As with DNMTs are present during DNA methylations, but not during DNA demethylation. Except for DNMT1, which is present during DNA demethylation to maintain certain methylations. The AID, ELP and BER proteins are all thought to be expressed during active DNA demethylation (adapted form (Feng et al., 2010)).

As previously mentioned, active DNA demethylation only takes place in the paternal genome after fertilization. In sperm some fundamental pluripotency transcription factors are methylated, and thus transcriptionally inactive. In ICM and ESCs these pluripotency transcription factors are unmethylated and therefore transcriptionally active. Thus when the sperm genome is demethylated some fundamental pluripotency transcription factors become activated, which is critical to develop the pluripotent ICM cells (Gehring et al., 2009; Feng et al., 2010).
DNA repair enzymes are known to be involved in active demethylation, as described earlier in this thesis. However, it is also suggested that elongator complex proteins (ELPs) are involved in demethylation of the paternal genome, because after knockdown of the ELP family demethylation was impaired (Feng et al., 2010; J. Zhao et al., 2010). ELPs are subunits of histone acetyltransferases and thus play a role in histone acetylation (Feng et al., 2010; J. Zhao et al., 2010). Therefore ELPs are also involved in transcriptional regulation (Feng et al., 2010; J. Zhao et al., 2010).
The maternal genome only undergoes passive demethylation (Feng et al., 2010; J. Zhao et al., 2010). During active demethylation the maternal genome as well as DMRs are protected from demethylation. (Feng et al., 2010; J. Zhao et al., 2010). When epigenetic modifications remain on a loci of the maternal allele, resulting in a silenced gene, the gene is called to be maternally imprinted. When on a loci of paternal allele, resulting in a silenced gene, the gene is called to be paternally imprinted(Feng et al., 2010Laprise, 2009). The maternally imprinted genes are especially sensitive to procedures needed for ART, such as oocyte isolation and manipulation in culture, and superovulation(Laprise, 2009; Santos et al., 2010).
6.	Discussion
Environmental factors can change gene expression in two ways; (1) through changing of the actual DNA sequence; (2) through modifying epigenetic modifications, resulting in epigenetic modification errors (Marques et al., 2010). It is suggested that the actions performed with ART procedures can act as environmental factors leading to epigenetic modification errors (Olson et al., 2005). Most genes that are imprinted with epigenetic modifications are important in fetal growth and neurodevelopment (J. Zhao et al., 2010). Therefore, these errors may contribute to the initiation and development of neurodevelopmental disorders, such as ASDs (Dubovicky, 2010; X. Zhao et al., 2007). The hypothesis of this thesis is; if there is a possible association between assisted conception and ASDs and other related disorders that may be due to epigenetic modification errors. It is of interest to examine such an association because nowadays 1% of all live births are born following ART and the use of ART treatments are still increasing each year (Fortunato & Tosti, 2011). Therefore, if this association is validated there will also be an increase of patients diagnosed with ASDs over the years. 
Epigenetic modifications are inherited in a parent-of-origin specific way, but are not changing the actual DNA sequence (Eun et al., 2010; Feng et al., 2010). It is possible, because of the parent-of-origin specific inheritance of epigenetic modifications, that epigenetic modification errors only appear in one of the two genomes, male or female, however it still can lead to genomic imprinting disorders (Santos et al., 2010). Several studies show an increase in genomic imprinting disorders, with an epigenetic origin, among children conceived through ART, considering a possible association between ART and epigenetics (Laprise, 2009; Peters et al., 2009; Santos et al., 2010). Three points are required for attention, regarding to ART; (1) germ cells are particularly sensitive to environmental changes (Santos et al., 2010); (2) immediately after fertilization the embryo is particularly sensitive for epigenetic changes (Peters et al., 2009); and (3) it is important to know when in epigenetic reprogramming the germ cells are removed from their natural environment (Laprise, 2009). The first point states the importance of the sensitivity of germ cells to environmental changes, which may induce epigenetic modification errors. Thus, the cells are not only immediately after fertilization sensitive to epigenetic changes, as stated in the second point, but also throughout the lifetime of the germ cell. The third point draws the attention to the point in epigenetic reprogramming of which the germ cells are removed from. If the female or male germ cells are removed before epigenetic reprogramming is completed, there is a risk of incomplete epigenetic reprogramming. Thus, with ART treatment germ cells are exposed to environmental factors during all of these vulnerable periods, which may result in epigenetic modification errors (Santos et al., 2010). However, no epigenetic differences are found in immature sperm compared to mature sperm, which may suggest that the point in epigenetic reprogramming of which the germ cells are removed from does not matter. Although, it is thought that the epigenetic modification errors, resulting in ASDs, may originate in the oocyte and thus would rule out the suggestion of sperm to be of influence (Laprise, 2009). One of the actions in ART treatment that act as an environmental factor that may lead to epigenetic modification errors is exogenous hormonal stimulation (Laprise, 2009), which is used in OI, IVF and IUI. Superovulation is an extreme form of OI (Georgia Reproductie Specialsts, 2007) and is shown to have an adverse effect on oocyte quality. This, also, may implicate that epigenetic modification errors originates in oocytes (Laprise, 2009). In addition, it is not excluded that the reduced fertility or infertility of the parents is due to epigenetic or genetic alterations leading to epigenetic errors that may result in neurodevelopmental disorders(Olson et al., 2005). Studies on animals suggest that the use of fragmented sperm DNA in ICSI may induce genetic or epigenetic alterations(Fortunato & Tosti, 2011). Regarding the outcome of long-term neurological deficits, such as neurodevelopmental disorders, with children born after ART, especially ICSI, is not known (Schendelaar et al., 2011). ICSI is only performed since 1992 and therefore the children born following ICSI are at the maximum of 18 years (Laprise, 2009). Therefore, a follow-up of children born through ICSI should be done, to investigate the long-term outcome of ICSI.
Despite of all the experimental evidence, a definite association between ART and epigenetic modification errors does not exist (Laprise, 2009). In addition, many risks that are associated with ART, such as long-term neurological morbidity, and increased risk of birth defects and chromosomal abnormalities, are also associated with factors like reduced fertility or infertility, maternal age, smoking, obesity and multiple pregnancies, which is the biggest risk of ART (Gelbaya, 2010). Also, with the use of ART evolutionary barriers are avoided and this may also play a major role on the inheritance of unnoticed epigenetic alterations, which may lead to neurodevelopmental disorders, such as ASDs (Laprise, 2009).
The etiology of ASDs are not fully understood, however, it is thought that a combination of heritable and environmental factors are responsible (Grafodatskaya et al., 2010; Whitelaw et al., 2007). This may all be dedicated to epigenetic modifications, because they are heritable but also modifiable by environmental factors (Grafodatskaya et al., 2010). Alcohol use, prenatal stress and smoking are some examples of environmental factors known to contribute or worsen the development of ASDs, possibly through epigenetic modification errors (Dubovicky, 2010). A candidate gene for AD and possibly also for the other ASDs is RELN. The RELN gene is regulated through epigenetic modification, more specific DNA methylation (Whitelaw et al., 2007). Another possible candidate gene for AD is MeCP2. This gene has an important role of the epigenetic regulation of gene transcription (Grafodatskaya et al., 2010; Monnerat et al., 2010). MeCP2 is also involved in 80% of the RTT cases, however, the mutations seen in RTT are different from those seen in AD. In addition, RTT patients with mutations in MeCP2 are mostly female and the few ASD patients that are caused by mutations in MeCP2 are mostly male (Grafodatskaya et al., 2010; Holt et al., 2010). Evidence indicate that environmental factors influence the initiation and development of ASDs, however, further research is needed to understand the etiology of ASDs better (Dubovicky, 2010).
Epigenetic modification errors are suggested to be the connection between ART and ASDs. Several associations were found, for example, children born after IVF are found to have a higher prevalence of diagnosed AS patients (Olson et al., 2005). It is thought that the side effect of ART are, via epigenetic modification changes, responsible for the initiation and development of ASDs (Olson et al., 2005). Also, an association was found between ART and AnS and among patients with AnS and PWS an increased risk of ASD is demonstrated (Grafodatskaya et al., 2010; Laprise, 2009). Whereas, many other retrospective studies show no association between ART and AnS and PWS (Fortunato & Tosti, 2011; Hvidtjorn et al., 2010; Laprise, 2009).





Before I conducted the data, I established the variables that I thought were useful. Next, I searched through the electronic patients files (EPD) to collect the data. The included variables were ‘sex’, ‘intelligence child’, ‘birth weight’, ‘gestational age’, ‘Apgar score’, ‘way of conception’, ‘maternal age’, ‘paternal age’, ‘maternal education level’, ‘paternal education level’, ‘parity’, ‘partus’, ‘breech presentation’, ‘multiple pregnancy’, ‘siblings’, ‘date of birth siblings’, ‘diagnosis sibling’, ‘family anamnesis’, ‘diagnosis of the child following DSM-IV-RT’, ‘diagnosis of the child following ADOS’, ‘use of medication during pregnancy’, ‘complications during pregnancy and birth’.
The ‘way of conception’ and the ‘diagnosis of the child following DSM-IV-RT/ADOS’ were obviously included to determine how many children diagnosed with ASD (autism, Asperger syndrome, PDD-NOS) or an ASD related syndrome (Fragile X, Rett, Angelman, Prader-Willi) and were conceived through assisted conception. With ASDs a male:female ratio of 4:1 was seen( Feng et al., 2010; Grafodatskaya et al., 2010; Holt et al., 2010) and to see if the ratio of the data and literature matched the variable ‘sex’ was included. To rule out that associations are found by accident due to other factors, the following variables are included; ‘parity’, ‘partus’, ‘breech presentation’, ‘multiple pregnancy’, ‘use of medication during pregnancy’, ‘complications during pregnancy’, ‘birth weight’, ‘gestational age’, ‘maternal age’, and ‘paternal age’. ‘Birth weight’ and ‘multiple pregnancies’ were included because they are associated with assisted conception. Maybe a low birth weight is seen in children with ASDs, because of a growth retardation. A growth retardation may also be seen in a short ‘gestational age’. Also, the ‘maternal and paternal age’ were of importance, because this may affect the quality of the sperm and oocytes, which may lead to an ASD or ASD related syndrome. Why patients get ASD or ASD related syndromes, could be the cause of inheritance of the parents, therefore, the next variables were included; ‘family anamnesis’, ‘siblings’, ‘diagnosis siblings’ and ‘maternal and paternal education level’. The variables I did not discuss were added for the completeness of the data, so the data can be used for other purposes.
The information I needed for my data was scattered in various letters found in the EPD. Also, not all patients dossiers were electronically available, which made it hard to find all of the information for every patient. Thus I learned to collect data in various places and bring them together in one data sheet. I included the patients that were new to the child and adolescence psychiatry department from 2007 till November 2010.
2.	Data interpretation
Although the data is not fully complete, I will try to interpret the data that I collected. After which, I may advice for future research.



































Total ASD related syndromes	3	0	0	0	3
					
Totaal	6	4	0	1	11
3.	Observation of an intake interview
The diagnosis of the patients were defined through an intake interview with the patient (and parents). There are two rooms, the interview room for the psychiatrist, patient and the parents and the observer room for the observers. When I attended such an interview I was in the room with the observers. Between the two rooms a one-way mirror existed, so the observers could see into the interview room, but the observer room was not seen from the interview room. Through microphones in the interview room everything said was heard in the observer room. The interview was recorded with sound and visuals. The layout of the interview room consists of two seats against one of the walls for the parents, a seat for the psychiatrist and a low children’s table and a little children’s seat. The psychiatrist will play all kinds of games with the child to investigate eye-contact, insight and teamwork. The observers also pay attention to these interactions and skills. After the interview the parents and patient leave and the observers and psychiatrist come together to score the patient in ADOS or DSM-IV-RT and determine what the diagnose is of this patient. 
4.	Day on the lab: Karyotype analysis and CGH array.
To see how a daily laboratory runs I went to the laboratory one day. Mr. A. van der Zwaag showed me a presentation where he explained what they do. They perform karyotype analysis or a CGH(comparative genome hybridization)-array of patients for which this is requested, such as; children that are stillborn; or that may have mental retardation due to a genetic cause; or for parents that may be carrier for a mutation that can lead to congenital anomalies. 
A karyogram is a picture of all 46 chromosomes, organized in 22 pairs and 1 pair of gender chromosomes. Therefore, a karyotype analysis, an analysis of the karyogram, provides the possibility to detect major chromosomal abnormalities. For example, a well known syndrome is Down syndrome, which is the result of a trisomie of chromosome 21. A CGH-array is provided when it is known that the abnormality in the genome is too small to see in a karyotype analysis, or followed after karyotype analysis when abnormalities are not detected.
Mevr. Gaby de Vries showed me around the laboratory. She showed me which steps were conducted for a CGH-array and what kind of machines they use for this technique. First, oligonucleotides, each oligonucleotide represents one gene of the human genome, are placed on a rectangular glass. After this, the clear DNA of the patient is duplicated and labeled with a green fluorescent label and the clear DNA of the controls is duplicated and labeled with a red fluorescent label. The DNA of the patient and controls are run through a filter and then resuspended in a buffer. A rubber is placed on the glass with the oligonucleotides so it is available to pipet the buffer with the DNA in the available space. The fluorescent DNA will hybridize on the oligonucleotides. After hybridization the glass with oligonucleotides and the bound DNA of controls and the patient will go into a machine. This machine will measure the intensity of the green and red fluorescence, which results in a pattern of green, red and yellow dots (Figure 5). The dots represent a higher amount of DNA in the patient when the dot lights green, in the control when the dot lights red and when a similar amount in patient and controls when yellow is found. 
 
Figure 5. CGH-array glass || The figure represents a glass, after hybridization of patient (green) and control (red) DNA.
5.	Discussion
The data that is collected is not complete, therefore, it is hard to draw any conclusions. The incompleteness of the data is partly due to the incompleteness of the information in the EPD. However, there may be useful information in this study for further research. The male:female ratio of ASDs that is found is lower than it is in the literature, this may be due to an undersized test group (191 patients). Also, not every new patient on the Child and Adolescent department was diagnosed with ASD or an ASD related syndrome, and a different list was used to score the patient (ADOS, ADI, or DSM-IV-RT). Frequently, ADOS and DSM-IV-RT are both taken.
For the comparison of the prevalence of assisted conception among patients diagnosed with ASD or ASD related syndromes with the prevalence of assisted conception in the general population more information is needed. For another study I recommend to include children from the same year over a period of 5 years.
For the psychiatry department, I recommend, to use one form with all the questions that include all the information. On this form questions should be added; if one of the parents has reduced infertility or is infertile, what the etiology of this reduced fertility is; the age of both parents; and the IQ of both parents. 
The male:female ratio of ASD patients in this study is quite similar to the ratio found in the literature. There appears to be no increased prevalence of assisted conception among patients with ASD or ASD related syndromes. No clear conclusion can be drawn from this data and thus further research should be done. Special attention should be given to the choice of children included in the study, e.g. children from the same year over 5 years, so the collected information can be compared with information from the general population. 

Conclusion
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